PT3345604T - Nalmefeno para redução do consumo de álcool em populações alvo específicas - Google Patents

Nalmefeno para redução do consumo de álcool em populações alvo específicas

Info

Publication number
PT3345604T
PT3345604T PT172060345T PT17206034T PT3345604T PT 3345604 T PT3345604 T PT 3345604T PT 172060345 T PT172060345 T PT 172060345T PT 17206034 T PT17206034 T PT 17206034T PT 3345604 T PT3345604 T PT 3345604T
Authority
PT
Portugal
Prior art keywords
nalmefene
reduction
specific target
alcohol consumption
target populations
Prior art date
Application number
PT172060345T
Other languages
English (en)
Portuguese (pt)
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48703496&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3345604(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of PT3345604T publication Critical patent/PT3345604T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
PT172060345T 2012-06-27 2013-06-27 Nalmefeno para redução do consumo de álcool em populações alvo específicas PT3345604T (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261664804P 2012-06-27 2012-06-27
US201261721539P 2012-11-02 2012-11-02
US201261736740P 2012-12-13 2012-12-13
US201361788810P 2013-03-15 2013-03-15

Publications (1)

Publication Number Publication Date
PT3345604T true PT3345604T (pt) 2023-07-17

Family

ID=48703496

Family Applications (3)

Application Number Title Priority Date Filing Date
PT172060345T PT3345604T (pt) 2012-06-27 2013-06-27 Nalmefeno para redução do consumo de álcool em populações alvo específicas
PT161874268T PT3138564T (pt) 2012-06-27 2013-06-27 Nalmefeno para a redução do consumo de álcool em populações alvo específicas
PT137324711T PT2866808T (pt) 2012-06-27 2013-06-27 Nalmefeno para a redução do consumo de álcool em populações alvo específicas

Family Applications After (2)

Application Number Title Priority Date Filing Date
PT161874268T PT3138564T (pt) 2012-06-27 2013-06-27 Nalmefeno para a redução do consumo de álcool em populações alvo específicas
PT137324711T PT2866808T (pt) 2012-06-27 2013-06-27 Nalmefeno para a redução do consumo de álcool em populações alvo específicas

Country Status (35)

Country Link
US (4) US20140005217A1 (enExample)
EP (5) EP4223296B1 (enExample)
JP (3) JP6258933B2 (enExample)
KR (1) KR20150023396A (enExample)
CN (1) CN104411313A (enExample)
AU (1) AU2013283281B2 (enExample)
BR (1) BR112014032555A2 (enExample)
CA (1) CA2874703C (enExample)
CL (1) CL2014003484A1 (enExample)
CO (1) CO7160087A2 (enExample)
CY (3) CY1118579T1 (enExample)
DK (3) DK3138564T3 (enExample)
EA (1) EA029908B1 (enExample)
ES (4) ES2663532T3 (enExample)
FI (1) FI3345604T3 (enExample)
HK (1) HK1255683A1 (enExample)
HR (4) HRP20230762T8 (enExample)
HU (4) HUE070621T2 (enExample)
IL (1) IL236035B (enExample)
LT (3) LT3138564T (enExample)
ME (2) ME02587B (enExample)
MX (1) MX371373B (enExample)
MY (1) MY166914A (enExample)
NZ (1) NZ702191A (enExample)
PH (1) PH12014502798A1 (enExample)
PL (4) PL3345604T3 (enExample)
PT (3) PT3345604T (enExample)
RS (2) RS57046B1 (enExample)
RU (1) RU2665373C2 (enExample)
SG (1) SG11201408704WA (enExample)
SI (3) SI2866808T1 (enExample)
SM (3) SMT201600471T1 (enExample)
UA (1) UA114199C2 (enExample)
WO (1) WO2014001427A1 (enExample)
ZA (1) ZA201409525B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140005217A1 (en) 2012-06-27 2014-01-02 H. Lundbeck A/S Nalmefene for reduction of alcohol consumption in specific target populations
JP6419780B2 (ja) * 2013-04-17 2018-11-07 ハー・ルンドベック・アクチエゼルスカベット 睡眠障害患者の治療のためのナルメフェン
MX2016013889A (es) 2014-04-22 2017-03-09 Otsuka Pharma Co Ltd Medicamento.
US20170071590A1 (en) * 2015-09-10 2017-03-16 Suture Armor Llc Suture anchor
KR102699603B1 (ko) 2018-04-20 2024-08-29 삼성전자주식회사 반도체 메모리 소자

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3814768A (en) 1971-11-26 1974-06-04 Lewenstein E 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts
US4535157A (en) 1983-11-01 1985-08-13 Key Pharmaceuticals, Inc. Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone
US5086058A (en) * 1990-06-04 1992-02-04 Alko Ltd. Method for treating alcoholism with nalmefene
RU2004107501A (ru) * 2001-08-14 2005-02-20 Байотай Терапис Корпорейшн (Fi) Способ лечения алкоголизма или злоупотребления алкоголем
UA102128C2 (en) * 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
JP5794980B2 (ja) 2009-05-25 2015-10-14 ハー・ルンドベック・アクチエゼルスカベット ナルトレキソンからの塩酸ナルメフェンの調製
HRP20170379T1 (hr) 2010-11-05 2017-05-05 H. Lundbeck A/S Postupak proizvodnje naltreksona
WO2012134410A1 (en) 2011-03-31 2012-10-04 Ak Kimya Ithalat-Ihracat Ve Sanayii A.S. Compositions of opioid antagonists and their use for treating scleroderma
US20140005217A1 (en) 2012-06-27 2014-01-02 H. Lundbeck A/S Nalmefene for reduction of alcohol consumption in specific target populations

Also Published As

Publication number Publication date
HRP20230762T1 (hr) 2023-10-13
MX371373B (es) 2020-01-28
PT3138564T (pt) 2018-04-03
PH12014502798A1 (en) 2015-02-09
US20160375007A1 (en) 2016-12-29
EP2866808A1 (en) 2015-05-06
CO7160087A2 (es) 2015-01-15
SMT201800164T1 (it) 2018-07-17
AU2013283281A1 (en) 2014-12-11
JP6258933B2 (ja) 2018-01-10
RS57046B1 (sr) 2018-05-31
PL3345604T3 (pl) 2023-08-28
AU2013283281B2 (en) 2017-04-20
CY1118579T1 (el) 2017-07-12
MX2014015488A (es) 2015-03-06
EP3138564B1 (en) 2018-01-31
US10034874B2 (en) 2018-07-31
EP2866808B1 (en) 2016-11-02
PL2866808T3 (pl) 2017-04-28
LT3345604T (lt) 2023-08-10
CA2874703A1 (en) 2014-01-03
SI3138564T1 (en) 2018-04-30
MY166914A (en) 2018-07-24
CN104411313A (zh) 2015-03-11
EP4541421A3 (en) 2025-06-18
US20140005217A1 (en) 2014-01-02
PL3138564T3 (pl) 2018-06-29
US20140005216A1 (en) 2014-01-02
HRP20180363T1 (hr) 2018-04-20
HUE031110T2 (en) 2017-06-28
KR20150023396A (ko) 2015-03-05
HK1208185A1 (en) 2016-02-26
RU2665373C2 (ru) 2018-08-29
SI2866808T1 (sl) 2017-01-31
HUE063313T2 (hu) 2024-01-28
HK1255683A1 (en) 2019-08-23
EP4223296A3 (en) 2023-09-27
HUE070621T2 (hu) 2025-06-28
SMT201600471B (it) 2017-03-08
LT2866808T (lt) 2017-01-10
EP3345604B1 (en) 2023-06-07
SI3345604T1 (sl) 2023-08-31
FI3345604T3 (fi) 2023-07-28
ME02587B (me) 2017-06-20
ES2609122T3 (es) 2017-04-18
UA114199C2 (uk) 2017-05-10
JP2019163275A (ja) 2019-09-26
HRP20250329T1 (hr) 2025-05-09
EP3345604A1 (en) 2018-07-11
ES3014068T3 (en) 2025-04-16
EP4223296B1 (en) 2025-01-29
PT2866808T (pt) 2017-01-03
SMT201600471T1 (it) 2017-03-08
ME03030B (me) 2018-10-20
CL2014003484A1 (es) 2015-02-27
DK3138564T3 (en) 2018-03-26
RS55456B1 (sr) 2017-04-28
JP6857684B2 (ja) 2021-04-14
HRP20161717T1 (hr) 2017-02-10
DK3345604T3 (da) 2023-07-24
IL236035A0 (en) 2015-01-29
CY1126140T1 (el) 2023-11-15
US9642849B2 (en) 2017-05-09
ES2663532T3 (es) 2018-04-13
SG11201408704WA (en) 2015-01-29
ZA201409525B (en) 2016-08-31
JP2018039810A (ja) 2018-03-15
PL4223296T3 (pl) 2025-04-14
EP4223296C0 (en) 2025-01-29
CA2874703C (en) 2022-08-23
CY1120097T1 (el) 2018-12-12
DK2866808T3 (en) 2017-01-16
RU2014151156A (ru) 2016-08-20
EP4223296A2 (en) 2023-08-09
EP3138564A1 (en) 2017-03-08
EA201492152A1 (ru) 2015-11-30
LT3138564T (lt) 2018-04-10
ES2950492T3 (es) 2023-10-10
HRP20230762T8 (hr) 2024-01-05
EA029908B1 (ru) 2018-05-31
US20180028526A1 (en) 2018-02-01
HUE036272T2 (hu) 2018-06-28
NZ702191A (en) 2017-06-30
WO2014001427A1 (en) 2014-01-03
EP4541421A2 (en) 2025-04-23
IL236035B (en) 2018-12-31
JP2015521647A (ja) 2015-07-30
BR112014032555A2 (pt) 2017-06-27

Similar Documents

Publication Publication Date Title
IL236525A0 (en) Antibodies against conserved targets
IL236625B (en) Processes for preparing derivatives of 3-carbonyl-4-hydroxy-isoquinoline and intermediates obtained in these processes
PT2748562T (pt) Identificação de consumos de serviços
GB201222625D0 (en) Improvements relating to tracking moving objects
GB201501116D0 (en) Improvements to refrigeration systems
ZA201409525B (en) Nalmefene for reduction of alcohol consumption in specific target populations
GB2505638B (en) Continuous culture
EP2591368A4 (en) METHOD FOR DETERMINING ETHANOL CONSUMPTION
GB2492873B (en) Soap Saving system
EP2845186A4 (en) EFFECTIVE ANTICRENELING IN ENERGY
EP2702462A4 (en) UNAUVIKED WAKING UP
GB201214566D0 (en) Improvements in and relating to virtualised systems
GB201114034D0 (en) Ashiur ayana ayana woman
GB201012404D0 (en) Taxi beeper
GB201110463D0 (en) Energy-efficient device
GB201222657D0 (en) Improvements relating to personal tracking identifiers
GB201108369D0 (en) Utility columns
AU338684S (en) Bolero
GB201102831D0 (en) Follicle culture
AU2011037V (en) DC2100 Dianella caerulea
AU2011036V (en) DC1000 Dianella caerulea
AU2011038V (en) DC4000 Dianella caerulea
AU2011039V (en) DC6000 Dianella caerulea